InsiderTrades

Form 4 for LRCX Lam Research

Accepted 2021-11-12 00:00:00 ET · period of report 2021-11-11 · accession 0000707549-21-000168 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-11-12 2021-11-11 LRCX ARCHER TIMOTHY Pres, CEO S - Sale+OE $613.59 -4,464 79.7K -5% -$2.74M
D 2021-11-12 2021-11-11 LRCX ARCHER TIMOTHY Pres, CEO M - OptEx $145.73 +4,464 84.2K +6% +$650.5K
D 2021-11-12 2021-11-11 LRCX ARCHER TIMOTHY Pres, CEO M - OptEx $145.73 -4,464 19.3K -19% -$650.5K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-11-11 S D 4,464 $613.59 79,724 D — — (F2) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 6,2021. (F1) The amount reported includes shares subject to unvested restricted stock units.
2 Common Common Stock 2021-11-11 M A 4,464 $145.73 84,188 D — — (F1) The amount reported includes shares subject to unvested restricted stock units.
3 Derivative Employee Stock Option (Right to Buy) 2021-11-11 M D 4,464 $145.73 19,347 D $145.73 · — to 2025-12-06 4,464 Common Stock (F3) The stock options will become exercisable over four years, a quarter on the one-year anniversary of the grant date and the remainder on a pro-rated basis on the 6th day of every month thereafter for the next 36 months.